News

He completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing extensive expertise to the management of treatment-resistant mental health ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...
As the opioid epidemic continues to plague the United States, Narcan and other treatments that administer naloxone have ...
Kindeva, a global contact development and manufacturing organization, was joined by Lieutenant Governor Jacqueline Coleman ...
For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...
Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.
ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.
SACRAMENTO – Governor Newsom announced that individual twin-packs of CalRx®-branded over-the-counter (OTC) naloxone HCL 4 mg nasal spray are now available to all Californians at a low price of $24 per ...
It’s election this weekend in Australia, and we’re all preparing to dictate what the next three years of our lives will look ...
Emergent BioSolutions signed an agreement worth around $65 million to supply the Ontario Ministry of Health with Narcan nasal spray. The contract will last a maximum of three years and supports the ...
Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...